A novel cell phenotypic profile approach for efficient screening and evaluation of TDP43 mediated therapeutic for ALS Posted on April 26, 2019August 21, 2019 by Suzanne Kerbavcic Duration: 2017-2018Donor/funding programme:MAECI / Exec. Prog. Scientific & Technological Cooperation – Italy & IsraelPartners:Emanuele Buratti Molecular Pathology, ICGEB Trieste, ItalyUniversity of Tel Aviv, IsraelShare this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Share on LinkedIn (Opens in new window) LinkedIn